Skip to content

KiDS education session in Indonesia

28 Aug 2024 | optima_admin

KiDS education session in Indonesia

28 Aug 2024 | optima_admin


On 28 August, IDF Blue Circle Voice Anita Sari, hosted a Kids and Diabetes in Schools (KiDS) session for pupils aged 6 -7 at BKB PAUD Kemuning 06, a primary school located in Jakarta, Indonesia. The session was part of a collaboration with Diabetes Initiative Indonesia and TP – PKK (Tim Penggerak Pemberdayaan dan Kesejahteraan Keluarga / Family Empowerment and Welfare Movement Team).

The diabetes education session introduced interactive educational games featuring children with diabetes. Another part of their training included recognising hypoglycemia or hyperglycemia in a friend with diabetes and what actions to take. They also learned about the different devices and supplies people with diabetes use, such as glucose monitors, CGMs and strips.

Anita moderated the activity, and Dr Burhan Gunawan, from Diabetes Initiative Indonesia, joined her to present diabetes prevention and management for the children and their families.

Figures released by the International Diabetes Federation in 2021 indicate that close to 20 million people live with diabetes in Indonesia, with the number expected to increase to 28 million by 2045.

The session was part of a KiDS initiative to partner with local advocates and associations to organise photo and video shoots during diabetes educational sessions. Assets from these sessions help illustrate the on-the-ground actions of KiDS advocates and further reinforce the importance of national policies that address diabetes at schools.

More reading

IDF Young Leaders host KiDS session in Portugal

12 Feb 2025 | International Diabetes Federation News

KiDS pilot sessions conducted in Madrid and Seville

12 Dec 2024 | International Diabetes Federation News

KiDS in Argentina presented at ISPAD

18 Oct 2024 | optima_admin News

Keep up to date with our latest updates

Subscribe to our e-alerts

Partners

KiDS is an IDF programme undertaken in partnership with the International Society of Pediatric and Adolescent Diabetes (ISPAD) and supported by an educational grant from Sanofi.